Cetera Advisors LLC Abb Vie Inc. Transaction History

Cetera Advisors LLC

$0
Q1 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $14.7 Million - $16.8 Million	92,259 Added 69.81%	224,418 $40.9 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $328,451 - $369,913	2,387 Added 1.84%	132,159 $20.5 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $1.04 Million - $1.21 Million	7,816 Added 6.41%	129,772 $19.3 Million
Q2 2023 Aug 09, 2023	BUY	$132.51 - $164.9 $2.07 Million - $2.57 Million	15,603 Added 14.67%	121,956 $16.4 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $471,139 - $542,587	3,258 Added 3.16%	106,353 $16.9 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $2.85 Million - $3.42 Million	20,603 Added 24.98%	103,095 $16.7 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $981,209 - $1.13 Million	7,311 Added 9.72%	82,492 $11.1 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $256,110 - $325,600	-1,861 Reduced 2.42%	75,181 $11.5 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $360,305 - $447,037	2,730 Added 3.67%	77,042 $12.5 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $614,499 - $777,519	-5,720 Reduced 7.15%	74,312 $10.1 Million
Q3 2021 Nov 16, 2021	BUY	$106.4 - $120.78 $664,787 - $754,633	6,248 Added 8.47%	80,032 $8.63 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $213,050 - $237,350	2,025 Added 2.82%	73,784 $8.31 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $911,186 - $1 Million	8,907 Added 14.17%	71,759 $7.77 Million
Q4 2020 Feb 17, 2021	BUY	$80.49 - $108.67 $547,895 - $739,716	6,807 Added 12.15%	62,852 $6.74 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $973,961 - $1.14 Million	11,337 Added 25.36%	56,045 $4.91 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $663,264 - $887,547	9,040 Added 25.34%	44,708 $4.39 Million
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $104,296 - $158,126	1,617 Added 4.75%	35,668 $2.72 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $108,555 - $135,826	-1,505 Reduced 4.23%	34,051 $3.02 Million
Q3 2019 Nov 06, 2019	BUY	$62.98 - $75.72 $116,450 - $140,006	1,849 Added 5.49%	35,556 $2.7 Million
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $36,463 - $46,608	-555 Reduced 1.62%	33,707 $2.46 Million
Q1 2019 May 06, 2019	BUY	$77.14 - $90.79 $13,885 - $16,342	180 Added 0.53%	34,262 $2.75 Million
Q4 2018 Feb 15, 2019	BUY	$77.85 - $96.01 $59,010 - $72,775	758 Added 2.27%	34,082 $3.13 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $163,060 - $181,272	-1,834 Reduced 5.22%	33,324 $3.14 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $284,153 - $336,217	-3,165 Reduced 8.26%	35,158 $3.25 Million
Q1 2018 May 09, 2018	SELL	$92.01 - $123.21 $426,742 - $571,447	-4,638 Reduced 10.8%	38,323 $3.63 Million
Q4 2017 Feb 08, 2018	SELL	$89.56 - $98.21 $433,022 - $474,845	-4,835 Reduced 10.12%	42,961 $4.16 Million
Q3 2017 Nov 16, 2017	SELL	$69.85 - $89.22 $359,587 - $459,304	-5,148 Reduced 9.72%	47,796 $4.25 Million
Q2 2017 Aug 14, 2017	BUY	N/A	52,944	52,944 $3.85 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisors LLC with notifications on news.

Account